Trade Summary

6 days ago, Krempa David, serving as Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON), sold 100,000 shares at $32.30 per share, for a total transaction value of $3,229,923.25. Following this transaction, Krempa David now holds 25,249 shares of ETON.

This sale represents a 79.84% decrease in Krempa David's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 6:28 PM ET, 5 days after the trade was made.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.